comparemela.com

Latest Breaking News On - Psoriasis activity severity index - Page 1 : comparemela.com

Study Confirms Efficacy of Guselkumab Treatment of Psoriasis After Ustekinumab Discontinuation

These multicenter, retrospective data highlight the use of guselkumab after discontinuing ustekinumab treatment up to 156 weeks of use.

Oral Therapies

This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.